Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67.6M
-
Number of holders
-
178
-
Total 13F shares, excl. options
-
40.6M
-
Shares change
-
+7.72M
-
Total reported value, excl. options
-
$1.74B
-
Value change
-
+$355M
-
Put/Call ratio
-
0.47
-
Number of buys
-
127
-
Number of sells
-
-50
-
Price
-
$42.84
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q3 2018
205 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q3 2018.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 178 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.6M shares
of 67.6M outstanding shares and own 60.12% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.91M shares), Vanguard Group Inc (3.79M shares), FRED ALGER MANAGEMENT INC (3.37M shares), FEDERATED INVESTORS INC /PA/ (1.61M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1.46M shares), LORD, ABBETT & CO. LLC (1.45M shares), STATE STREET CORP (1.15M shares), TimesSquare Capital Management, LLC (1.09M shares), Redmile Group, LLC (1.07M shares), and TWO SIGMA INVESTMENTS, LP (1.03M shares).
This table shows the top 178 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.